PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Similar documents
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Inferior Vena Cava Filters

INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008

Deep Venous Thrombosis, Pulmonary Embolus and IVC Filters. Michael Meuse, M.D. Vascular and Interventional Radiology

I am NOT: Disclosures. The Problem of the Con-Position Non Thinking! Against New Ideas. Against New Therapies. Against Endovascular Therapies

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006)

THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012

Inferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown

IVC Filters: For Whom, Why and When?

Thrombosis & Hemostasis Summit of North America 2016Apr16. IVC Filters

IVC filter retrieval program effects on retrieval rates and number of patients lost to follow-up

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Top 5 (or so) Hematology Consults. Tom DeLoughery, MD FACP FAWM. Oregon Health and Sciences University DISCLOSURE

Top Ten Reasons For Failure To Prevent Postoperative Thrombosis

IVC Filters: A new era of responsibility

Inferior Vena Cava Filter Retrieval

ORIGINAL INVESTIGATION. Indications, Complications, and Management of Inferior Vena Cava Filters

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

Intervention for Deep Venous Thrombosis and Pulmonary Embolus

VTE in the Trauma Population

Handbook for Venous Thromboembolism

Special comment. (inferior vena cava filter, IVCF) Mobin-Uddin % [4] 1 IVCF

Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:

Mabel Labrada, MD Miami VA Medical Center

What is the impact of Superficial Vein Thrombosis?

SAFETY AND EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS USED TO PROTECT AGAINST PULMONARY EMBOLUS

Division of Vascular Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Supplementary Online Content

Copyright Protected. There is considerable debate over what constitutes. Inferior Vena Cava Filter Placement in Orthopedic Surgery

Venous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH

Controversies in Venous Thromboembolism

The Evidence Base for Treating Acute DVT

incidence of cancer-associated thrombosis (CAT) is further increased by additional risk factors such as chemotherapeutic 2

DEEP VEIN THROMBOSIS (DVT): TREATMENT

Post-Traumatic Thromboembolism. Pathogenesis, Diagnosis and Prevention M. Margaret Knudson, MD

Superficial Thrombophlebitis Treatment Guideline Review

J Jpn Coll Angiol, 2009, 49:

Interventional Treatment VTE: Radiologic Approach

Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach

Pictorial review of IVC filters and their complications

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Inferior Vena Cava Filter for DVT

Pulmonary embolism (PE) has often been considered a

Management of Cancer Associated Thrombosis (CAT) where data is lacking. Tim Nokes Haematologist, Derriford Hospital, Plymouth

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Bard Meridian Filter Fracture

Patients with cancer are at a greater risk of developing venous thromboembolism than non-cancer patients, partly due to the 1

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

IVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices. Paul D. Stein, MD

How long to continue anticoagulation after DVT?

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Complications of Inferior Vena Caval Filters

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School

Perioperative Management of the Anticoagulated Patient

Case-based topics to touch on Beware of devices that sit in veins. Asymptomatic PE management conundrum. nd Should we be testing for hypercoagulabilit

Venous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma

Successful recanalisation of venous thrombotic occlusions with Aspirex mechanical thrombectomy. Michael K. W. Lichtenberg

Interventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC

Prevention of Venous Thromboembolism in High-Risk Patients

Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis

Deep venous thrombosis (DVT) is a common problem among

Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:

How to prevent thrombotic diseases? Sergio Fusco, MD

Suprarenal Inferior Vena Cava Filters: A 20-Year Single-Center Experience

GLIOMA - VENOUS THROMBOEMBOLISM. Miguel Navarro. Hospital Universitario de Salamanca-IBSAL

Current issues in the management of Superficial Vein Thrombosis - SVT

Medical Patients: A Population at Risk

Perforated inferior vena cava filter removal by concurrent femoral and internal jugular vein approaches

Inferior vena cava filters: current best practices

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Deep vein thrombosis (DVT) is a pervasive LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF ACUTE DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM *

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Spontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: A Case Report 1

Is Oral Rivaroxaban Safe and Effective in the Treatment of Patients with Symptomatic DVT?

M Johnson Disclosures

DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS

HISTORICALLY, INSERTION

Anticoagulation for prevention of venous thromboembolism

Case. Case. Management of Pulmonary Embolism in the ICU

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

Complications of inferior vena cava filters

VERNACULAR Trial & Clinical Experience with the VENOVO Venous Stent

October 2017 Pulmonary Embolism

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

Inferior Vena Cava Filter Migration to the Right Ventricle: A Case Report and Review of Filter Migration and Misdeployment

Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A

Joint Theater Trauma System Clinical Practice Guideline

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

I-Ming Chen, MD. Endovascular Stenting for Palliative Treatment of Superior Vena Cava Syndrome in End-Stage Lung Cancer

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

CADTH Rapid Response Report: ASA for Venous Thromboembolism Prophylaxis: Evidence for Clinical Benefit and Harm

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group

Transcription:

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational and Research Trust (UK) European Venous Forum North American Thrombosis Forum International Union of Angiology and Union Internationale du Phlebologie 1

2 Inferior Vena Cava Filters Chapter 16

Indications for Inferior Vena Cava Filters Indications for inferior vena cava (IVC) filters are categorized Absolute Relative Prophylactic In the truest sense, all IVC filters are prophylactic Describes the use of an IVC filter in patients at risk but without an identifiable PE or DVT 3

Indications for Inferior Vena Cava Filters Absolute Indications Absolute indications include Venous thromboembolic complications associated with a contraindication to anticoagulation Documented failure of anticoagulation Complications of anticoagulation in patients with VTE Evidence suggests most patients treated with IVC filters do not have any of the 3 accepted absolute indications 1 1. Girard P, et al. Chest 2002; 122(3):963-7. 4

Indications for Inferior Vena Cava Filters Relative Indications A relative indication exists when a patient has a VTE complication and the risk of PE is high Bleeding complications are high with anticoagulation Relative indications include Large free-floating thrombus in the vena cava Massive PE Recurrent PE in the presence of a filter DVT in patients with limited cardiopulmonary reserve Those suspected to be noncompliant with anticoagulation 5

6 Indications for Inferior Vena Cava Filters Prophylactic Indications Prophylactic indications occur in patients who have neither DVT nor PE but the risk of a VTE complication is high and the efficacy of alternative forms of prophylaxis is considered poor or associated with high bleeding risk

Evidence for IVC Filters IVC Filters Versus No Filtration A RCT evaluated the benefit of filters in patients with acute DVT undergoing routine anticoagulation 1 Primary endpoint was PE at 12 days Patients randomized to IVC filters had significantly fewer PE versus those without a filter (1.1% versus 4.8%) Patients with IVC filters had an increased incidence of recurrent DVT at 2 years (20.8% versus 11.6%) Eight-year follow-up data demonstrated Recurrent PE rate was 6.2% in patients with IVC filters versus 15.1% in controls Recurrent DVT was higher patients with IVC filters (35.7% vs 27.5%) than controls Mortality was equivalent 1. Decousus H, et al. N Engl J Med 1998; 338(7):409-15. 7

Thrombotic Risk by IVC Filters Observed that thrombotic risk and retrievability varies between filters 1 Filters producing regions of flow stagnation and recirculation at the wall of the vena cava. May produce turbulence and thus pose an increased risk of thrombosis 2,3 Hemodynamic observations have translated into clinically relevant findings as observed in a randomized trial 4 1. Karmy-Jones R, et al. J Trauma 2007; 62(1):17-24; discussion 24-5. 2. Harlal A, et al. J Vasc Interv Radiol 2007; 18(1 Pt 1):103-15. 3. Couch GG, et al. J Vasc Surg 2000; 31(3):539-49. 4. Usoh F, et al. J Vasc Surg 2010; 52(2):394-9. 8

Cochrane Review of IVC Filters A Cochrane review of the use IVC filters for prevention of PE determined a lack of information on the effectiveness 1 Strong recommendations cannot be provided for IVC filters on the basis of established and current evidence 1. Young T, et al. Cochrane Database Syst Rev 2007(4):CD006212. 9

Optional or Retrievable IVC Filters Increasing numbers of optional (retrievable) IVC filters are being used A systematic literature review of retrievable IVC filters comprising of 37 studies and 6834 patients found a mean retrieval rate of 34% 8 Complication rates included DVT (5.4%) Filter migration (1.3%) Vena cava thrombosis/stenosis (2.8%) IVC filter fractures accounted for 22% of complications 1. Angel LF, et al. J Vasc Interv Radiol 2011; 22(11):1522-1530 e3. 10

Insertion of IVC Filter Problems associated with IVC filter insertion may be categorized as early or late complications 1 Early complications, including incomplete or asymmetric deployment, malpositioning or tilting, had a reported incidence of 1% to 12.4% Late complications, including filter migration, filter disruption, caval thrombosis, caval perforation and recurrent pulmonary embolism, were reported in 1.7% to 33% Some complications vary by filter type 1 Filter migration and tilting more common with Bard filters IVC thrombosis was commonly seen with TrapEase (Cordis) filters in patients with malignancy or other hypercoagulable states The incidence of other complications appeared to be similar among various IVC filters 1. Rao B, et al. AJR Am J Roentgenol 2012; 198(6):W605-10. 11

Recommendations Inferior Vena Cava Filters Patients with PE or proximal DVT with contraindications to anticoagulation should receive an IVC filter Level of evidence: Moderate Patients who have recurrent acute PE despite therapeutic anticoagulation should receive an IVC filter Level of evidence: Low Patients with acute PE and poor cardiopulmonary reserve should be considered for an IVC filter Level of evidence: Low 12

Recommendations Inferior Vena Cava Filters Patients who receive a retrievable IVC filter should be evaluated for filter removal within the specific filter s retrieval window Level of evidence: Low An IVC filter should not be used routinely as an adjunct to anticoagulation Level of evidence: Low Patients receiving an IVC filter due to a contraindication to anticoagulation should be restarted on anticoagulation whenever the contraindication no longer exists Level of evidence: Low 13